Dongzhu Duan

Dr. Dongzhu Duan

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
RLRuyi Li
Ruyi Li
XSXin Song
Xin Song
YGYanan Guo
Yanan Guo
PSPeng Song
Peng Song
DDDongzhu Duan
Dongzhu Duan
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen
Tumor-associated angiogenesis is a key target for anti-cancer therapy. The imbalance between pro-angiogenic and anti-angiogenic signals elicited by tumor cells or tumor microenvironment always results in activating “angiogenic switch”. Tumor angiogenesis functions in multi-aspects of tumor biology, including endothelial cell apoptosis, tumor metastasis, and cancer stem cell proliferation. Numerous studies have indicated the important roles of inexpensive and less toxic natural products in targeting tumor angiogenesis-associated cytokines and apoptotic signaling pathways. Our current knowledge of tumor angiogenesis is based mainly on experiments performed on cells and animals, so we summarized the well-established models for angiogenesis both in vitro and in vivo. In this review, we classified and summarized the anti-angiogenic natural agents (Polyphenols, Polysaccharides, Alkaloids, Terpenoids, Saponins) in targeting various tumor types according to their chemical structures at present, and discussed the mechanistic principles of these natural products on regulating angiogenesis-associated cytokines and apoptotic signaling pathways. This review is to help understanding the recent progress of natural product research for drug development on anti-tumor angiogenesis.

1 July 2015 in Aquatic Toxicology
Verified
Journal Article
Closed access
ZZZhao Zhao
Zhao Zhao
HSHuijuan Shi
Huijuan Shi
DDDongzhu Duan
Dongzhu Duan
HLHongmei Li
Hongmei Li
TLTingwen Lei
Tingwen Lei
YZYun Zhao
Yun Zhao

28 December 2017 in BMC Systems Biology
Verified
Journal Article
Open access
PDF file
LWLe Wang
Le Wang
NTNana Tan
Nana Tan
JHJiayao Hu
Jiayao Hu
HWHuan Wang
Huan Wang
DDDongzhu Duan
Dongzhu Duan
XWXiaoling Wang
Xiaoling Wang
Osmanthus fragrans has been used as folk medicine for thousands of years. The extracts of Osmanthus fragrans flowers were reported to have various bioactivities including free radical scavenging, anti-inflammation, neuroprotection and antitumor effects. However, there is still lack of knowledge about its essential oil. In this work, we analyzed the chemical composition of the essential oil from Osmanthus fragrans var. thunbergii by GC-MS. A complex network approach was applied to investigate the interrelationships between the ingredients, target proteins, and related pathways for the essential oil. Statistical characteristics of the networks were further studied to explore the main active ingredients and potential bioactivities of O. fragrans var. thunbergii essential oil. A total of 44 ingredients were selected from the chemical composition of O. fragrans var. thunbergii essential oil, and that 191 potential target proteins together with 70 pathways were collected for these compounds. An ingredient-target-pathway network was constructed based on these data and showed scale-free property as well as power-law degree distribution. Eugenol and geraniol were screened as main active ingredients with much higher degree values. Potential neuroprotective and anti-tumor effect of the essential oil were also found. A core subnetwork was extracted from the ingredient-target-pathway network, and indicated that eugenol and geraniol contributed most to the neuroprotection of this essential oil. Furthermore, a pathway-based protein association network was built and exhibited small-world property. MAPK1 and MAPK3 were considered as key proteins with highest scores of centrality indices, which might play an important role in the anti-tumor effect of the essential oil. This work predicted the main active ingredients and bioactivities of O. fragrans var. thunbergii essential oil, which would benefit the development and utilization of Osmanthus fragrans flowers. The application of complex network theory was proved to be effective in bioactivities studies of essential oil. Moreover, it provides a novel strategy for exploring the molecular mechanisms of traditional medicines.

1 May 2018 in Tetrahedron Letters
Verified
Journal Article
Closed access
JXJian Xiao
Jian Xiao
LLLi-Bin Lin
Li-Bin Lin
JHJia-Yao Hu
Jia-Yao Hu
DDDongzhu Duan
Dongzhu Duan
WSWei Shi
Wei Shi
XWXiaoling Wang
Xiaoling Wang

6 July 2024 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
DDDongzhu Duan
Dongzhu Duan
XGXiangyu Guo
Xiangyu Guo
JTJingjing Tian
Jingjing Tian
MLMi Li
Mi Li
XJXiaojie Jin
Xiaojie Jin
XWXiaoling Wang
Xiaoling Wang

1 August 2025 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
PSPeng Song
Peng Song
TLTongtong Liu
Tongtong Liu
YZYinfang Zhang
Yinfang Zhang
TSTingting Shao
Tingting Shao
RLRongkun Li
Rongkun Li
DDDongzhu Duan
Dongzhu Duan
Breast cancer (BC) is the most commonly diagnosed malignancy among women globally. While treatments such as chemotherapy and endocrine therapy have contributed to improving survival rates, there remains a critical need for more effective therapeutic options. Traditional Chinese Medicine (TCM), with a history spanning thousands of years, has long been utilized in the management of BC. This includes a wide range of practices, such as the use of traditional compound prescriptions, Chinese medicine monomers and extracts, acupuncture, moxibustion, and mind-body therapies. This review summarizes the brief history and experience of TCM in treating BC refer to numerous ancient Chinese medical texts, and explores the role of various TCM approaches in the treatment of BC, providing an in-depth analysis of their potential benefits. Additionally, it addresses the current limitations and challenges in researching TCM’s effectiveness for BC. Through this review, we aim to offer valuable insights into how TCM can complement conventional therapies and enhance outcomes for patients with BC.